香港股市 已收市

Pacira BioSciences, Inc. (PCRX)

NasdaqGS - NasdaqGS 即時價格。貨幣為 USD。
加入追蹤清單
27.21-0.11 (-0.40%)
收市:04:00PM EDT
27.21 0.00 (0.00%)
收市後: 04:03PM EDT

Pacira BioSciences, Inc.

5401 West Kennedy Boulevard
Suite 890
Tampa, FL 33609
United States
813 553 6680
https://www.pacira.com

版塊Healthcare
行業Drug Manufacturers - Specialty & Generic
全職員工711

高階主管

名稱頭銜支付行使價出生年份
Mr. Daryl GauglerChief Operating Officer778.77k115k1962
Ms. Kristen Williams J.D.Chief Administrative Officer & Secretary799.63k857.7k1974
Mr. Anthony Molloy III, Esq.Chief Legal & Compliance Officer581.41k802.07k1974
Mr. David M. StackAdvisor1.54M4.37M1950
Mr. Frank D. LeeCEO & Director1968
Ms. Lauren Bullaro RikerPrincipal Accounting Officer & Senior VP of Finance288.81k196.6k1979
Susan MescoHead of Investor Relations
Mr. Richard KahrVice President of Human Resources
Dr. Jonathan Slonin M.D.Chief Medical Officer815.25k1975
Mr. Christopher C. YoungChief Manufacturing Officer1972
截止 2022年12月31日為止計算的金額,現金賠償則計算至上一個財政年度末止。薪資是指薪俸、獎金等。已行使價是指財政年度期間已行使的期權價值。貨幣為 USD。

描述

Pacira BioSciences, Inc. engages in the development, manufacture, marketing, distribution, and sale of non-opioid pain management and regenerative health solutions to healthcare practitioners in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid handheld cryoanalgesia device used to produce controlled doses of cold temperature to targeted nerves. It has a development and commercialization, and supply agreement with Aratana Therapeutics, Inc. for NOCITA, a bupivacaine liposome injectable suspension product. The company was formerly known as Pacira Pharmaceuticals, Inc. and changed its name to Pacira BioSciences, Inc. in April 2019. Pacira BioSciences, Inc. was incorporated in 2006 and is headquartered in Tampa, Florida.

公司管治

截至 2024年5月1日 止,Pacira BioSciences, Inc. 的 ISS 管治質素評分為 5。 Pillar 分數正在審核中:2;董事會:3;股東權利:7;現金賠償:6。

企業管治評分的資料提供: Institutional Shareholder Services (ISS). 評分將以 1 至 10 分顯示 (與指數或地區相關)。1 分表示較低的管治風險,而 10 分表示較高的管治風險。